✦ LIBER ✦

Treatment of elderly patients with type 2 diabetes mellitus: A systematic review of the benefits and risks of dipeptidyl peptidase-4 inhibitors

✍ Scribed by Sherwyn L. Schwartz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dipeptidyl Peptidase-4 Inhibitors for th

✍ Dr. Joshua J. Neumiller; Dr. Lindy Wood; Mr. R. Keith Campbell 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB

Longer term safety of dipeptidyl peptida

✍ K. Gooßen; S. Gräber 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 726 KB

Dipeptidyl peptidase-4 inhibitors in the

✍ C. F. Deacon 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 711 KB

Dipeptidyl Peptidase-4 Inhibitors for th

✍ Herman, G A; Stein, P P; Thornberry, N A; Wagner, J A 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 160 KB

EFFECT OF THE DIPEPTIDYL PEPTIDASE-4 INH

✍ Sara Stafford; Dariush Elahi; Graydon S. Meneilly 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Saxagliptin: a new dipeptidyl peptidase-

✍ Carolyn F. Deacon; Jens J. Holst 📂 Article 📅 2009 🏛 Springer Healthcare Communications 🌐 English ⚖ 223 KB